Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20081
20101
20111
20121
20171
20182
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Amgen2
Bayer1
Dong-A ST Co., Ltd.1
Eli Lilly and Company1
Huons Co., Ltd.1
Sanofi1
Seoul National University Bundang Hospital1
Yeouido St. Mary's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal12
Bone Diseases, Metabolic3
Osteoporosis3
Bone Diseases2
Musculoskeletal Diseases2
Diabetes Mellitus, Type 21
Hypercholesterolemia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.